Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hoyle

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
British Journal of Haematology|May 1, 1989
AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialC F Hoyle, M de Bastos, K Wheatley, et al.
Leukemia|August 30, 2008
A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trialsC M Lucas, L Wang, G M Austin, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
British Journal of Haematology|May 1, 1989
AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialC F Hoyle, M de Bastos, K Wheatley, et al.
Leukemia|August 30, 2008
A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trialsC M Lucas, L Wang, G M Austin, et al.
Pageof 4